Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented new data from the ongoing Phase 1 study...

Updated clinical data for Vitrakvi® (larotrectinib) in adult and pediatric patients with TRK fusion cancer demonstrated an overall response rate (ORR) of 79 percent (n=121; 95% CI, 72–85),...

Wormhole Labs today announced a partnership with Twitch, the leading service and community for multiplayer entertainment, to unveil Wormhole™, a powerful social connecting tool designed for...

ColorComm, Inc., the nation's leading platform addressing diversity & inclusion across the communications, marketing, advertising, and media industries, will host the 2nd Annual ColorComm Next...

The American Society of Cannabis Medicine announced today that members of its leadership have been asked to participate at the Second Annual Update on Medical Cannabis Friday, Sept. 27 presented...